The well of novel antidepressants: running dry.
作者信息
Blier Pierre
出版信息
J Psychiatry Neurosci. 2010 Jul;35(4):219-20. doi: 10.1503/jpn.100098.
Abstract
摘要
相似文献
1
The well of novel antidepressants: running dry.新型抗抑郁药之泉：即将枯竭。
J Psychiatry Neurosci. 2010 Jul;35(4):219-20. doi: 10.1503/jpn.100098.
2
[Clinical studies: the missing antidepressants].[临床研究：缺失的抗抑郁药]
Neuropsychopharmacol Hung. 2005 Sep;7(3):103-4.
3
Qualms about balms: perspectives on antidepressants.对抗抑郁药的疑虑：观点剖析
J Nerv Ment Dis. 2001 May;189(5):296-8. doi: 10.1097/00005053-200105000-00004.
4
Agomelatine: innovation for the benefit of depressed patients.阿戈美拉汀：造福抑郁症患者的创新药物。
CNS Drugs. 2009;23 Suppl 2:1-2. doi: 10.2165/11318610-000000000-00000.
5
[If the general practitioner has to decide: what is the evidence for the selection of antidepressants?].[如果全科医生必须做出决定：选择抗抑郁药的依据是什么？]
Dtsch Med Wochenschr. 2014 Aug;139(34-35):1727-30. doi: 10.1055/s-0034-1370270. Epub 2014 Aug 12.
6
Agomelatine: a novel atypical antidepressant.阿戈美拉汀：一种新型非典型抗抑郁药。
J Psychosoc Nurs Ment Health Serv. 2007 Dec;45(12):13-7. doi: 10.3928/02793695-20071201-04.
7
[QTc prolongation during treatment with agomelatine].[阿戈美拉汀治疗期间的QTc间期延长]
Psychiatr Prax. 2010 Nov;37(8):405-7. doi: 10.1055/s-0030-1248578. Epub 2010 Sep 16.
8
Agomelatine-Related Shift to Mania in a Patient With Recurrent Depressive Disorder.一例复发性抑郁症患者使用阿戈美拉汀后转为躁狂
Prim Care Companion CNS Disord. 2017 Oct 26;19(5):16l02079. doi: 10.4088/PCC.16l02079.
9
Agomelatine-induced gynaecomastia.阿戈美拉汀所致男性乳房发育症。
Aust N Z J Psychiatry. 2013 Dec;47(12):1211-2. doi: 10.1177/0004867413499079. Epub 2013 Jul 23.
10
[A study of the efficacy and safety of valdoxan in the treatment of a depressive episode].伏硫西汀治疗抑郁发作的疗效与安全性研究
Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(9):36-42.
引用本文的文献
1
"Novel Psychopharmacology for Depressive Disorders".《抑郁障碍的新型精神药理学》
Adv Exp Med Biol. 2021;1305:449-461. doi: 10.1007/978-981-33-6044-0_22.
2
Orphans to the rescue: orphan G-protein coupled receptors as new antidepressant targets.孤儿受体来救援：孤儿G蛋白偶联受体作为新型抗抑郁靶点
J Psychiatry Neurosci. 2020 Sep 1;45(5):301-303. doi: 10.1503/jpn.200149.
3
Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review.双相情感障碍联合用药的患病率及临床特征：一项系统评价
Neuropsychiatr Dis Treat. 2016 Mar 31;12:719-35. doi: 10.2147/NDT.S100846. eCollection 2016.
4
A Canadian Primary Care Sentinel Surveillance Network Study Evaluating Antidepressant Prescribing in Canada From 2006 to 2012.一项加拿大初级保健哨点监测网络研究，评估2006年至2012年加拿大的抗抑郁药处方情况。
Can J Psychiatry. 2015 Dec;60(12):564-70. doi: 10.1177/070674371506001207.
5
Inflaming depression.炎症引发的抑郁症
J Psychiatry Neurosci. 2011 Sep;36(5):291-5. doi: 10.1503/jpn.110071.
6
Monoamine oxidase A inhibitor occupancy during treatment of major depressive episodes with moclobemide or St. John's wort: an [11C]-harmine PET study.用[11C]-哈尔明 PET 研究观察吗氯贝胺或贯叶连翘治疗重性抑郁发作时单胺氧化酶 A 抑制剂的占有率。
J Psychiatry Neurosci. 2011 Nov;36(6):375-82. doi: 10.1503/jpn.100117.
7
Possible directions for the discovery of new antidepressant treatments.发现新型抗抑郁治疗方法的可能方向。
J Psychiatry Neurosci. 2011 Jan;36(1):3-5. doi: 10.1503/jpn.100169.
本文引用的文献
1
A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder.一项双盲、随机、安慰剂对照、活性对照研究，评估 Lu AA21004 在重度抑郁症患者中的疗效。
Int J Neuropsychopharmacol. 2012 Jun;15(5):589-600. doi: 10.1017/S1461145711001027. Epub 2011 Jul 18.
2
Cytochrome P450 2D6 phenotype predicts antidepressant efficacy of venlafaxine: a secondary analysis of 4 studies in major depressive disorder.细胞色素 P450 2D6 表型预测文拉法辛的抗抑郁疗效：4 项重性抑郁障碍研究的二次分析。
J Clin Psychiatry. 2010 Nov;71(11):1482-7. doi: 10.4088/JCP.08m04773blu. Epub 2010 Apr 6.
3
Effects of acute and sustained administration of the catecholamine reuptake inhibitor nomifensine on the firing activity of monoaminergic neurons.急性和持续给予儿茶酚胺再摄取抑制剂诺米芬新对单胺能神经元放电活动的影响。
J Psychopharmacol. 2010 Aug;24(8):1223-35. doi: 10.1177/0269881109348178. Epub 2009 Nov 25.
4
Agomelatine: efficacy at each phase of antidepressant treatment.阿戈美拉汀：在抗抑郁治疗各阶段的疗效
CNS Drugs. 2009;23 Suppl 2:41-7. doi: 10.2165/11318660-000000000-00000.
5
Comparison of pharmacokinetic profiles of brand-name and generic formulations of citalopram and venlafaxine: a crossover study.西酞普兰和文拉法辛品牌药与仿制药的药代动力学特征比较：一项交叉研究。
J Clin Psychiatry. 2009 Jul;70(7):958-66. doi: 10.4088/jcp.09m05315.
6
Sustained administration of bupropion alters the neuronal activity of serotonin, norepinephrine but not dopamine neurons in the rat brain.安非他酮的持续给药改变了大鼠脑中血清素、去甲肾上腺素神经元的活性，但未改变多巴胺能神经元的活性。
Neuropharmacology. 2008 Dec;55(7):1191-8. doi: 10.1016/j.neuropharm.2008.07.028. Epub 2008 Jul 30.
7
Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women.绝经后长期雌激素国际女性研究（WISDOM）中记录的主要发病率：一项绝经后女性激素替代疗法的随机对照试验。
BMJ. 2007 Aug 4;335(7613):239. doi: 10.1136/bmj.39266.425069.AD. Epub 2007 Jul 11.
8
A dose-finding study of duloxetine based on serotonin transporter occupancy.一项基于5-羟色胺转运体占有率的度洛西汀剂量探索研究。
Psychopharmacology (Berl). 2006 Apr;185(3):395-9. doi: 10.1007/s00213-005-0304-0. Epub 2006 Feb 28.
9
Catecholaminergic strategies for the treatment of major depression.治疗重度抑郁症的儿茶酚胺能策略。
Curr Drug Targets. 2006 Feb;7(2):149-58. doi: 10.2174/138945006775515464.
10
Escitalopram versus citalopram: the surprising role of the R-enantiomer.艾司西酞普兰与西酞普兰对比：R-对映体的惊人作用。
Psychopharmacology (Berl). 2004 Jul;174(2):163-76. doi: 10.1007/s00213-004-1865-z.
Zotero 插件